MedTrace Logo

Balanced Propofol Sedation During Upper Endoscopy in Morbidly Obese Patients

NCT00782873 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2008-10-31

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety of propofol-based, gastroenterologist-administered sedation in severely obese patients (BMI≥35) undergoing upper endoscopy.

The investigators aim to test the hypothesis that it is safe to use balanced-propofol, gastroenterologist-administered sedation in obese patients.

Conditions

Sponsors & Collaborators

  • Research Associates of New York, LLP

    lead OTHER

Principal Investigators

  • Lawrence B Cohen, MD · Research Associates of New York

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2008-08-31
Completion
2008-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00782873 on ClinicalTrials.gov